Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.13 USD | -0.79% | -5.14% | +7.15% |
Financials (USD)
Sales 2024 * | 168M | Sales 2025 * | 299M | Capitalization | 1.45B |
---|---|---|---|---|---|
Net income 2024 * | -48M | Net income 2025 * | 58M | EV / Sales 2024 * | 8.52 x |
Net cash position 2024 * | 19.66M | Net cash position 2025 * | 70.24M | EV / Sales 2025 * | 4.62 x |
P/E ratio 2024 * |
-27.3
x | P/E ratio 2025 * |
25.3
x | Employees | 154 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.29% |
Latest transcript on Avadel Pharmaceuticals plc
1 day | -0.79% | ||
1 week | -5.14% | ||
Current month | -5.14% | ||
1 month | -4.42% |
Managers | Title | Age | Since |
---|---|---|---|
Gregory Divis
CEO | Chief Executive Officer | 57 | 17-01-02 |
Thomas McHugh
DFI | Director of Finance/CFO | 59 | 19-12-01 |
Scott Macke
COO | Chief Operating Officer | - | 14-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Ende
BRD | Director/Board Member | 55 | 18-11-30 |
Gregory Divis
CEO | Chief Executive Officer | 57 | 17-01-02 |
Mark McCamish
BRD | Director/Board Member | 72 | 19-12-04 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 15.13 | -0.79% | 637,921 |
24-06-06 | 15.25 | +2.56% | 813,491 |
24-06-05 | 14.87 | -3.82% | 1,224,560 |
24-06-04 | 15.46 | -1.28% | 869,208 |
24-06-03 | 15.66 | -1.82% | 648,315 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.15% | 1.45B | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.85% | 248B | |
-1.15% | 219B | |
+11.23% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- AVDL Stock